Abstract: Diarrhea in foals can be associated with disruption of the intestinal microbiota (dysbiosis). Effective management of intestinal dysbiosis in foals has not been demonstrated. Objective: Fecal microbiota transplantation (FMT) in foals with diarrhea influences the intestinal microbiota and improves clinical and clinicopathological outcomes. Methods: Twenty-five foals <6 months of age with diarrhea and systemic inflammatory response syndrome at 3 veterinary hospitals. Methods: A prospective randomized placebo-controlled cohort study. Foals in the FMT group (n = 19) or control group (n = 9) received FMT or electrolyte solution once daily for 3 days. Fecal samples were obtained on Day 0 (D0), D1, D2, D3, and D7. Within group and between group data analyses were performed for clinical, clinicopathological, and microbiota variables. Results: Treatment had no effect on survival (FMT 79%; control 100%, P = .3) or resolution of diarrhea (FMT 68%; control 55%, P = .4). On D3, the white blood cell count of the FMT group was lower than the control group (D3 FMT group median 6.4 g/L [5-8.3 g/L]; D3 control group median 14.3 g/L [6.7-18.9 g/L] P = .04). Heart rate reduced over time in the FMT group (D0 median 80 bpm [60-150 bpm]; D2 median 70 bpm [52-110 bpm] [P = .005]; and D3 median 64, [54-102 bpm] [P < .001]). Phylum Verrucomicrobiota, genus Akkermansia, and family Prevotellaceae were enriched in the FMT group on D1 (linear discriminate analysis > 4). Conclusions: In foals with diarrhea, FMT appears safe and can be associated with some clinical and microbiota changes suggestive of beneficial effect.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This study investigated the effects of fecal microbiota transplantation (FMT) on foals under 6 months old suffering from diarrhea, focusing on clinical outcomes and changes in their intestinal microbiota.
The study aimed to evaluate whether FMT could improve health indicators and restore healthy gut bacteria compared to a control treatment with electrolyte solution.
Background and Purpose
Diarrhea in foals can lead to disruption of their intestinal microbiota, a condition called dysbiosis, which negatively impacts gut health and overall recovery.
Currently, effective treatments targeting microbiota restoration in foals with diarrhea are not well established.
The study’s objective was to determine if FMT could beneficially influence gut microbiota and clinical outcomes in diarrheic foals.
Study Design and Methods
Researchers conducted a prospective, randomized, placebo-controlled cohort study across three veterinary hospitals.
Participants consisted of 25 foals under 6 months old presenting with diarrhea and systemic inflammatory response syndrome (SIRS).
Foals were assigned to two groups:
FMT group (n=19): received fecal microbiota transplantation once daily for three days.
Control group (n=9): received an electrolyte solution placebo once daily for three days.
Fecal samples were collected from all foals on Day 0 (baseline), and Days 1, 2, 3, and 7 to analyze gut microbiota changes over time.
Clinical variables (e.g., white blood cell count, heart rate), clinicopathological data, and microbiota profiles were compared within groups over time and between groups.
Key Findings
Survival rates were not significantly different between groups: 79% in FMT group vs. 100% in controls (P=0.3).
Resolution of diarrhea showed no statistically significant difference: 68% in FMT group vs. 55% in controls (P=0.4).
By Day 3, foals in the FMT group had a significantly lower median white blood cell count compared to controls, indicating possible reduced inflammation or improved immune response:
FMT group median: 6.4 g/L (range 5-8.3 g/L)
Control group median: 14.3 g/L (range 6.7-18.9 g/L)
P=0.04 (significant)
Heart rates declined significantly over time in the FMT group, suggesting clinical improvement:
Day 0 median: 80 bpm (range 60-150 bpm)
Day 2 median: 70 bpm (range 52-110 bpm), P=0.005
Day 3 median: 64 bpm (range 54-102 bpm), P<0.001
Microbiota analysis showed enrichment of particular beneficial bacterial groups in the FMT group on Day 1:
Phylum Verrucomicrobiota
Genus Akkermansia
Family Prevotellaceae
This suggests that FMT can alter the intestinal bacterial composition toward potentially healthier profiles.
Conclusions and Implications
FMT was safe when used in foals with diarrhea, with no adverse survival outcomes noted.
While FMT did not significantly change survival rates or diarrhea resolution compared to controls, it was associated with some clinical improvements (e.g., reduced white blood cell count and heart rate) that may indicate a beneficial effect on inflammation and overall health.
Importantly, FMT appeared to shift the gut microbiota toward a composition featuring key beneficial bacteria, which could promote gut health and recovery.
These findings suggest that fecal microbiota transplantation warrants further investigation as a potential treatment for managing dysbiosis and improving clinical outcomes in foals with diarrhea.
Cite This Article
APA
Bell J, Radial SL, Cuming RS, Trope G, Hughes KJ.
(2024).
Effects of fecal microbiota transplantation on clinical outcomes and fecal microbiota of foals with diarrhea.
J Vet Intern Med, 38(5), 2718-2728.
https://doi.org/10.1111/jvim.17185
Charles Sturt University School of Agricultural, Environmental and Veterinary Sciences, Wagga Wagga, New South Wales, Australia.
Radial, Sharanne L
Charles Sturt University School of Agricultural, Environmental and Veterinary Sciences, Wagga Wagga, New South Wales, Australia.
Cuming, Rosemary S
Scone Equine Hospital, Scone, New South Wales, Australia.
Trope, Gareth
South Eastern Equine Hospital, Narre Warren North, Victoria, Australia.
Hughes, Kristopher J
Charles Sturt University School of Agricultural, Environmental and Veterinary Sciences, Wagga Wagga, New South Wales, Australia.
MeSH Terms
Animals
Horses
Diarrhea / veterinary
Diarrhea / therapy
Diarrhea / microbiology
Fecal Microbiota Transplantation / veterinary
Horse Diseases / therapy
Horse Diseases / microbiology
Female
Feces / microbiology
Male
Gastrointestinal Microbiome
Prospective Studies
Treatment Outcome
Animals, Newborn
Dysbiosis / veterinary
Dysbiosis / therapy
Cohort Studies
Grant Funding
Agrifutures Australia
Conflict of Interest Statement
Kristopher J. Hughes serves as Associate Editor for the Journal of Veterinary Internal Medicine. He was not involved in review of this manuscript. No other authors declare a conflict of interest.
Slovis NM, Elam J, Estrada M, Leutenegger CM. Infectious agents associated with diarrhoea in neonatal foals in central K entucky: a comprehensive molecular study. Equine Vet J 2014;46:311‐316.
Costa MC, Arroyo LG, Allen‐Vercoe E. Comparison of the fecal microbiota of healthy horses and horses with colitis by high throughput sequencing of the V3‐V5 region of the 16S rRNA gene (equine fecal microbiota). Vet J 2012;7:e41484.
Bolyen E, Rideout JR, Dillon MR. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 2019;37:852‐857.
Li B, Zhang X, Guo F, Wu W, Zhang T. Characterization of tetracycline resistant bacterial community in saline activated sludge using batch stress incubation with high‐throughput sequencing analysis. Water Res 2013;47:4207‐4216.
Lozupone CA, Hamady M, Kelley ST, Knight R. Quantitative and qualitative β diversity measures lead to different insights into factors that structure microbial communities.. Appl Environ Microbiol 2007;73:1576‐1585.
Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples).. Biometrika 1965;52:591‐611.
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing.. J R Stat Soc B Methodol 1995;57:289‐300.
Segata N, Izard J, Waldron L. Metagenomic biomarker discovery and explanation.. Genome Biol 2011;12:R60.
Kruskal WH, Wallis WA. Errata: use of ranks in one‐criterion variance analysis.. J Am Stat Assoc 1953;48:907‐911.
Maslen BN, Duff C, Clark SA, van der Werf J, White JD, Pant SD. Increased yearling weight gain is associated with a distinct faecal microbial profile.. Animals 2023;13:3062.
Dias DPM, Sousa SS, Molezini FA, Ferreira HSD, Campos R. Efficacy of faecal microbiota transplantation for treating acute colitis in horses undergoing colic surgery.. Pesqui Vet Bras 2018;38:1564‐1569.
Everard A, Belzer C, Geurts L. Cross‐talk between Akkermansia muciniphila and intestinal epithelium controls diet‐induced obesity.. Proc Nat Acad Sci– U S A 2013;110:9066‐9071.
Bedarf JR, Hildebrand F, Coelho LP. Functional implications of microbial and viral gut metagenome changes in early stage L‐DOPA‐naïve Parkinson's disease patients.. Genome Med 2017;9:39.
Tian R, Chong CJ, Bai YY, Chen N, Qiao RR, Wang K, Wang YW, Zhao P, Zhao CB, Tang YP, Zhang L, Zhang Q. The role of gut microbiota in diarrhea and its alleviation through microbiota-targeted interventions. Front Microbiol 2025;16:1630823.